Areas of Focus
At Acadia, we see promise in therapeutic areas where the unmet need remains high.
What We Do
From Parkinson’s disease psychosis to Rett syndrome, we are fiercely committed to addressing unmet needs in neuroscience. Learn about the areas where we aim to elevate life for patients.
Parkinson’s Disease Psychosis (PDP)
PDP is typically characterized by hallucinations and delusions. Around 50% of patients with Parkinson’s disease may experience hallucinations and/or delusions over the course of their disease.
Rett Syndrome (RTT)
RTT is a rare neurodevelopmental disorder that occurs primarily in females following apparently normal development for the first 6-18 months of life. RTT occurs worldwide in approximately one of every 10,000 to 15,000 female births (6,000 to 9,000 patients in the U.S.).
Alzheimer’s Disease Psychosis (ADP)
Approximately 6 million people in the United States are living with Alzheimer’s disease, with this number projected to rise as the elderly population grows. Hallucinations and delusions associated with ADP affect around 30% of patients with AD dementia.
Negative Symptoms of Schizophrenia (NSS)
Patients may experience NSS, which may include a reduction or absence of behaviors related to motivation and interest or expression.
Get in Touch
How can we help? Click here to get in touch with us directly. Our team is committed to supporting you.